Search filters

List of works by Julien Mazieres

A phase II randomized study evaluating the addition of iniparib to gemcitabine plus cisplatin as first-line therapy for metastatic non-small-cell lung cancer.

scientific article published on 19 August 2014

A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer

scientific article published on 7 November 2015

A randomized phase II study of the MEK1/MEK2 inhibitor trametinib (GSK1120212) compared with docetaxel in KRAS-mutant advanced non-small-cell lung cancer (NSCLC)†.

scientific article published on 26 February 2015

An analysis of treatment delays of thoracic cancers: a prospective study

scientific article published on 28 October 2013

An anti-Wnt-2 monoclonal antibody induces apoptosis in malignant melanoma cells and inhibits tumor growth.

scientific article

Assessing the multimodal management of advanced solitary fibrous tumors of the pleura in a routine practice setting.

scientific article published in February 2015

Basic fibroblast growth factor-2/beta3 integrin expression profile: signature of local progression after chemoradiotherapy for patients with locally advanced non-small-cell lung cancer.

scientific article published on 20 April 2009

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

scientific article published on 21 December 2015

Bevacizumab in Patients with Nonsquamous Non-Small Cell Lung Cancer and Asymptomatic, Untreated Brain Metastases (BRAIN): A Nonrandomized, Phase II Study.

scientific article published on 22 January 2015

Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations.

scientific article published in April 2005

Bronchial colonisation in patients with lung cancer: a prospective study

scientific article published on October 25, 2012

Bronchoscopic Multimodal Management of Tracheal Neurofibroma

scientific article published on 01 October 2016

Characteristics and Clinical Outcomes of Sarcomatoid Carcinoma of the Lung

scientific article published on 17 March 2016

Characteristics of lung cancer in women: importance of hormonal and growth factors.

scientific article

Circulating tumor DNA genomics reveals potential mechanisms of resistance to BRAF-targeted therapies in BRAF-mutant metastatic non-small cell lung cancer patients

scientific article published on 28 August 2020

Crizotinib therapy for advanced lung adenocarcinoma and a ROS1 rearrangement: results from the EUROS1 cohort

scientific article

Customized adjuvant phase II trial in patients with non-small-cell lung cancer: IFCT-0801 TASTE

scientific article published on 17 March 2014

DNA replication stress response involving PLK1, CDC6, POLQ, RAD51 and CLASPIN upregulation prognoses the outcome of early/mid-stage non-small cell lung cancer patients.

scientific article

Dabrafenib in patients with BRAF(V600E)-positive advanced non-small-cell lung cancer: a single-arm, multicentre, open-label, phase 2 trial.

scientific article published on 11 April 2016

Dabrafenib plus trametinib in patients with previously treated BRAF(V600E)-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial

scientific article published on 03 June 2016

Dermatologic complications of anti-PD-1/PD-L1 immune checkpoint antibodies

scientific article published on 28 April 2016

Detection and Monitoring of the BRAF Mutation in Circulating Tumor Cells and Circulating Tumor DNA in BRAF-Mutated Lung Adenocarcinoma.

scientific article

Detection of circulating tumor cells from lung cancer patients in the era of targeted therapy: promises, drawbacks and pitfalls

scientific article published on May 2014

Diagnostic value of bronchoscopy, CT and transbronchial biopsies in diffuse pulmonary lymphangiomatosis: case report and review of the literature.

scientific article

Efficacy of first-line chemotherapy in patients with advanced lung sarcomatoid carcinoma.

scientific article published in December 2013

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

scientific article

Erratum to "Sunitinib in patients with advanced thymic malignancies: cohort from the French RYTHMIC network" [Lung Cancer, 97 (July 2016), 99-104]

scientific article published on 06 October 2016

Expression of TTF-1 and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade

scientific article published on 01 August 2004

Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial

scientific article published on 07 June 2019

High-throughput somatic mutation profiling in pulmonary sarcomatoid carcinomas using the LungCarta™ Panel: exploring therapeutic targets.

scientific article

Hospital undertaking of patients with a resection of lung cancer

scientific article published on 13 November 2012

How to treat the relapse of NSCLC after surgery and chemotherapy? IFTC 0702 randomized phase III study

scientific article

Impact of induction treatment on postoperative complications in the treatment of non-small cell lung cancer.

scientific article published on July 2007

Incidence and characteristics of bronchial colonisation in patient with lung cancer: a retrospective study of 388 cases

scientific article published on 3 February 2011

Inhibition of Wnt-1 signaling induces apoptosis in beta-catenin-deficient mesothelioma cells.

scientific article published in May 2004

Inhibition of Wnt-2-mediated signaling induces programmed cell death in non-small-cell lung cancer cells.

scientific article published on August 2004

Inhibition of Wnt16 in human acute lymphoblastoid leukemia cells containing the t(1;19) translocation induces apoptosis

scientific article

Integration of interventional bronchoscopy in the management of lung cancer

scientific article

KRAS and bronchial adenocarcinoma. Between disappointments and hopes

scientific article published on 28 October 2015

Large cell neuroendocrine carcinoma of the lung: pathological study and clinical outcome of 18 resected cases

scientific article published on 01 September 2002

Limited operation for severe multisegmental bilateral bronchiectasis

scientific article published on 01 February 2003

Loss of RhoB expression in human lung cancer progression.

scientific article published on April 2004

Loss of RhoB expression promotes migration and invasion of human bronchial cells via activation of AKT1.

scientific article published on 14 July 2009

Lung cancer in women and pregnancy: towards a hormonal origin?

scientific article published in October 2007

Lung cancer that harbors an HER2 mutation: epidemiologic characteristics and therapeutic perspectives

scientific article

Management of malignant pleural mesothelioma: a French multicenter retrospective study (GFPC 0802 study).

scientific article published on 6 November 2015

Meeting report: 2nd meeting of the European Thoracic Oncology Platform (ETOP)

scientific article published on 01 April 2010

Molecular epidemiology of the lung cancer

scientific article

Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS-mutated lung adenocarcinoma.

scientific article published on 22 July 2016

Nivolumab for treating non-small cell lung cancer.

scientific article

Non-small cell lung cancer recurrence following surgery and perioperative chemotherapy: Comparison of two chemotherapy regimens (IFCT-0702: A randomized phase 3 final results study).

scientific article published on 27 May 2015

Perception of lung cancer among the general population and comparison with other cancers

scientific article published in March 2015

Phase II study of sunitinib in patients with non-small cell lung cancer and irradiated brain metastases.

scientific article

Prognostic factors associated with interventional bronchoscopy in lung cancer

scientific article published on 03 October 2013

Prospective molecular marker analyses of EGFR and KRAS from a randomized, placebo-controlled study of erlotinib maintenance therapy in advanced non-small-cell lung cancer

scientific article published on 3 October 2011

RASSF1A Suppresses the Invasion and Metastatic Potential of Human Non-Small Cell Lung Cancer Cells by Inhibiting YAP Activation through the GEF-H1/RhoB Pathway

scientific article published on 12 January 2016

Radiofrequency ablation for non-small-cell lung cancer in a single-lung patient: case report and review of the literature.

scientific article published on 06 March 2013

Randomized phase II trial evaluating treatment with EGFR-TKI associated with anti-estrogen in women with non-squamous advanced stage NSCLC: IFCT-1003 LADIE trial

scientific article published on 06 March 2020

RhoB determines tumor aggressiveness in a murine EGFRL858R-induced adenocarcinoma model and is a potential prognostic biomarker for Lepidic lung cancer.

scientific article published on 15 October 2014

RhoB loss induces Rac1-dependent mesenchymal cell invasion in lung cells through PP2A inhibition

scientific article published on 6 July 2015

Routine molecular profiling of patients with NSCLC - Authors' reply

scientific article published on 01 September 2016

Specificities of lung adenocarcinoma in women who have never smoked.

scientific article published in July 2013

Stenting for superior vena cava obstruction associated with lung cancer: monocentric study

scientific article published on September 2009

Sunitinib in patients with advanced thymic malignancies: Cohort from the French RYTHMIC network

scientific article published on 3 May 2016

Targeted Therapy for Patients with BRAF-Mutant Lung Cancer: Results from the European EURAF Cohort

scientific article published on 20 July 2015

Targeting the immune system to treat lung cancer: rationale and clinical experience.

scientific article published on 31 March 2015

The Prognostic Significance of Lymphovascular Invasion on Biopsy Specimens in Lung Cancer Treated With Definitive Chemoradiotherapy

scientific article published on January 1, 2012

The RAS-related GTPase RHOB confers resistance to EGFR-tyrosine kinase inhibitors in non-small-cell lung cancer via an AKT-dependent mechanism.

scientific article published on 21 December 2016

Tracheal Glomangioleiomyoma Treated by Multimodal Interventional Bronchoscopy.

scientific article published in April 2016

Ultra-sensitive EGFR T790M Detection as an Independent Prognostic Marker for Lung Cancer Patients Harboring EGFR del19 Mutations and Treated with First-generation TKIs

scientific article published on 01 April 2019

[A brief overview of a lung cancer biomarker: thymidylate synthase]

scientific article published on 14 May 2011

[Adverse effects of new biological therapies for non-small-cell bronchial cancer].

scientific article

[An unusual mediastinal mass].

scientific article published on 11 December 2013

[COPD and lung cancer: epidemiological and biological links]

scientific article published on 22 March 2012

[Efficacy and tolerance of bevacizumab in non-small cell lung cancer: preliminary report]

scientific article published on 01 August 2008

[Introduction to the Thematic Series "Targeted therapies in lung cancers"]

scientific article published on 01 February 2014

[New targets and new drugs in thoracic oncology].

scientific article

[Radiofrequency ablation of primary lung cancer: a single centre experience]

scientific article published in November 2009

[Socio-anthropological perspective of the under nutrition care of cancer patients]

scientific article published on 01 March 2014

[Surgical management and outcomes of lung cancer in women - results from the Epithor database]

scientific article published on 01 September 2007

[Thermal ablation: tolerance and efficacy in a population mostly composed of primary lung cancers].

scientific article published in September 2010

[Which factors influence inclusion of thoracic cancer patients in clinical trials?]

scientific article published on 11 November 2014